Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Study Questions 'Off-Label' Use of Antipsychotics


Related Encyclopedia
 border=
Alzheimer's Disease
Dementia
Depression (Major Depressive Disorder)
Dysthymia
More...

Related Healthscout Videos
 border=
Howard: The Helping Hand for Stroke Survivors
Fixing Torn Hearts
Medicine's Next Big Thing? Growing Hearts
How can a supportive family help?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Bipolar Disorder Animation
Depression
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Ambien
Avandia
Coumadin
More...

Related News Articles
 border=
Statin Therapy Helps Diabetic Patients
Vitamin C May Play Role in Stroke Prevention
Health Tip: Postpartum Depression
Priming Heart Before an Attack Could Limit Damage
More...


Page:  << Prev | 1 | 2 | 3

The study authors called for more head-to-head trials of the drugs.

"The clearest finding was that the quality of evidence for the most common uses was not very clear-cut, which doesn't prove the case that these aren't appropriate to consider in individual patients. But it does say that given the amount of use they're getting, we need some better research to try to clarify how to identify the right patients to get these drugs," Atkins said.

But Corcoran and others called for a different approach.

Text Continues Below



"Our sense is not more head-to-head trials but the need to develop other kinds of treatments for disorders other than psychosis, drugs that are safer, more appropriate, using rationale drug design," she said.

More information

View the full report at AHRQ.

Page:  << Prev | 1 | 2 | 3

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 1/19/2007

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





New Features

New ADHD Site!

SOURCES: David Atkins, M.D., chief medical officer, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, Md.; Julio Licinio, M.D., chairman, department of psychiatry and behavioral sciences, University of Miami Miller School of Medicine; Cheryl Corcoran, M.D., assistant professor of psychiatry, Columbia University, and researcher in schizophrenia, New York State Psychiatric Institute, New York City; Jan. 17, 2007, Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics, Agency for Healthcare Research and Quality


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map